Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ron Lindsay, Clay Patterson

Premium

Sequenom said this week that Ron Lindsay, the firm's executive VP of strategic planning, will retire from the company at the end of 2013, although he will continue to serve as a member of the firm's board of directors. Lindsay began working part-time for the firm in August.


Clay Patterson, managing director of Cerner Capital, has joined the board of directors at Claritas Genomics as part of an agreement between the two companies that included an investment by Cerner into Claritas.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.